ÂÜÀòÂÒÂ×

Dr. Schlüter was CFO of CureVac GmbH from 2010 to 2015. During his tenure at CureVac, he was instrumental in the transformation of a 70 employee R&D-driven company to a 170-employee customer-centric and value-focused corporation that entered into several strategic partnerships with in-house cGMP-manufacturing. From the time of his appointment in 2010, the company secured more than €200 million in funding and increased the company value more than tenfold to more than €1 billion.

Dr. Schlüter has 25 years of professional experience within the fields of Finance and Life Sciences. He holds a PhD in computational finance and also studied business administration.